Literature DB >> 8947041

RIP mediates tumor necrosis factor receptor 1 activation of NF-kappaB but not Fas/APO-1-initiated apoptosis.

A T Ting1, F X Pimentel-Muiños, B Seed.   

Abstract

The CD95 (Fas/APO-1) and tumor necrosis factor (TNF) receptor pathways share many similarities, including a common reliance on proteins containing 'death domains' for elements of the membrane-proximal signal relay. We have created mutant cell lines that are unable to activate NF-kappaB in response to TNF. One of the mutant lines lacks RIP, a 74 kDa Ser/Thr kinase originally identified by its ability to associate with Fas/APO-1 and induce cell death. Reconstitution of the line with RIP restores responsiveness to TNF. The RIP-deficient cell line is susceptible to apoptosis initiated by anti-CD95 antibodies. An analysis of cells reconstituted with mutant forms of RIP reveals similarities between the action of RIP and FADD/MORT-1, a Fas-associated death domain protein.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8947041      PMCID: PMC452440     

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  31 in total

1.  A novel RING finger protein interacts with the cytoplasmic domain of CD40.

Authors:  H M Hu; K O'Rourke; M S Boguski; V M Dixit
Journal:  J Biol Chem       Date:  1994-12-02       Impact factor: 5.157

2.  A novel domain within the 55 kd TNF receptor signals cell death.

Authors:  L A Tartaglia; T M Ayres; G H Wong; D V Goeddel
Journal:  Cell       Date:  1993-09-10       Impact factor: 41.582

Review 3.  The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death.

Authors:  C A Smith; T Farrah; R G Goodwin
Journal:  Cell       Date:  1994-03-25       Impact factor: 41.582

4.  Molecular cloning and expression of the human 55 kd tumor necrosis factor receptor.

Authors:  H Loetscher; Y C Pan; H W Lahm; R Gentz; M Brockhaus; H Tabuchi; W Lesslauer
Journal:  Cell       Date:  1990-04-20       Impact factor: 41.582

5.  A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor.

Authors:  M Rothe; S C Wong; W J Henzel; D V Goeddel
Journal:  Cell       Date:  1994-08-26       Impact factor: 41.582

6.  Cross-linking CD40 on B cells rapidly activates nuclear factor-kappa B.

Authors:  I Berberich; G L Shu; E A Clark
Journal:  J Immunol       Date:  1994-11-15       Impact factor: 5.422

7.  High-frequency mutagenesis of human cells and characterization of a mutant unresponsive to both alpha and gamma interferons.

Authors:  R McKendry; J John; D Flavell; M Müller; I M Kerr; G R Stark
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

8.  Fc gamma receptor activation induces the tyrosine phosphorylation of both phospholipase C (PLC)-gamma 1 and PLC-gamma 2 in natural killer cells.

Authors:  A T Ting; L M Karnitz; R A Schoon; R T Abraham; P J Leibson
Journal:  J Exp Med       Date:  1992-12-01       Impact factor: 14.307

9.  A potential mechanism of "cross-talk" between the p55 tumor necrosis factor receptor and Fas/APO1: proteins binding to the death domains of the two receptors also bind to each other.

Authors:  E E Varfolomeev; M P Boldin; T M Goncharov; D Wallach
Journal:  J Exp Med       Date:  1996-03-01       Impact factor: 14.307

10.  Fas and tumor necrosis factor receptor-mediated cell death: similarities and distinctions.

Authors:  M V Clement; I Stamenkovic
Journal:  J Exp Med       Date:  1994-08-01       Impact factor: 14.307

View more
  189 in total

Review 1.  Signal transduction by tumour necrosis factor and tumour necrosis factor related ligands and their receptors.

Authors:  B G Darnay; B B Aggarwal
Journal:  Ann Rheum Dis       Date:  1999-11       Impact factor: 19.103

2.  The Epstein-Barr virus oncoprotein latent membrane protein 1 engages the tumor necrosis factor receptor-associated proteins TRADD and receptor-interacting protein (RIP) but does not induce apoptosis or require RIP for NF-kappaB activation.

Authors:  K M Izumi; E D Cahir McFarland; A T Ting; E A Riley; B Seed; E D Kieff
Journal:  Mol Cell Biol       Date:  1999-08       Impact factor: 4.272

3.  Mechanisms of apoptosis.

Authors:  J C Reed
Journal:  Am J Pathol       Date:  2000-11       Impact factor: 4.307

4.  Epstein-Barr latent membrane protein 1 transformation site 2 activates NF-kappaB in the absence of NF-kappaB essential modifier residues 133-224 or 373-419.

Authors:  Daniela Boehm; Benjamin E Gewurz; Elliott Kieff; Ellen Cahir-McFarland
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-05       Impact factor: 11.205

5.  Vav family proteins couple to diverse cell surface receptors.

Authors:  S L Moores; L M Selfors; J Fredericks; T Breit; K Fujikawa; F W Alt; J S Brugge; W Swat
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

6.  The alpha and beta subunits of IkappaB kinase (IKK) mediate TRAF2-dependent IKK recruitment to tumor necrosis factor (TNF) receptor 1 in response to TNF.

Authors:  A Devin; Y Lin; S Yamaoka; Z Li; M Karin
Journal:  Mol Cell Biol       Date:  2001-06       Impact factor: 4.272

7.  Critical roles of c-Rel in autoimmune inflammation and helper T cell differentiation.

Authors:  Brendan A Hilliard; Nicola Mason; Lingyun Xu; Jing Sun; Salah-Eddine Lamhamedi-Cherradi; Hsiou-Chi Liou; Christopher Hunter; Youhai H Chen
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

8.  A20 inhibits tumor necrosis factor (TNF) alpha-induced apoptosis by disrupting recruitment of TRADD and RIP to the TNF receptor 1 complex in Jurkat T cells.

Authors:  Kai-Li He; Adrian T Ting
Journal:  Mol Cell Biol       Date:  2002-09       Impact factor: 4.272

9.  Autocrine TNFalpha signaling renders human cancer cells susceptible to Smac-mimetic-induced apoptosis.

Authors:  Sean L Petersen; Lai Wang; Asligul Yalcin-Chin; Lin Li; Michael Peyton; John Minna; Patrick Harran; Xiaodong Wang
Journal:  Cancer Cell       Date:  2007-11       Impact factor: 31.743

10.  Restoration of NF-kappaB activation by tumor necrosis factor alpha receptor complex-targeted MEKK3 in receptor-interacting protein-deficient cells.

Authors:  Marzenna Blonska; Yun You; Romas Geleziunas; Xin Lin
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.